- Study at RCSI
- Schools, Faculties, Departments
- Faculty of Medicine & Health Sciences
- School of Medicine
- School of Pharmacy
- School of Physiotherapy
- School of Postgraduate Studies
- School of Nursing & Midwifery
- Academic Departments
- Institute of Leadership
- Health Professions Education Centre (HPEC)
- Simulation
- Student, Academic & Regulatory Affairs
- CoMPPAS
- Faculty of Sports and Exercise Medicine
- Faculty of Nursing & Midwifery
- Faculty of Dentistry
- Faculty of Radiologists
- Alumni
- Surgical Affairs
- Research & Innovation
- Innovation
- Strategic Academic Recruitment Programme
- Research News & Events
- Research Areas
- Principal Investigators
- Research Networks & Centres
- Technology Cores & Research Facilities
- Research Office
- Employment Opportunities
- PhD Projects and Postgraduate Training Opportunities
- Research Ethics
- Technology Transfer Office & Management of Intellectual Property
- Research by Faculty
- Research by Academic Department
- Research by School
- Human Resources Strategy for Researchers (HRS4R)
- About RCSI
- Council
- CEO and Senior Management
- History
- Contact us and location
- RCSI Strategic Plan 2018 - 2022
- Publications
- Communications
- Venue hire
- 26 York Street
- Equality Diversity and Inclusion
- Athena SWAN
- RCSI and the wider community
- Quality Enhancement Office
- Academic Health Centre
- Irish Society of Urology
- Freedom of Information (FOI)
- Eduroam
- Green Campus
- RCSI Collaborate
- RCSI International
Pharmaceutical & Medicinal Chemistry
Chemistry in RCSI goes back a long way, the first Professor of Chemistry, James Apjohn, having been appointed in 1828. Over the years the Department has kept pace with and in some cases has spearheaded College developments.
It is now responsible for undergraduate chemistry teaching in the Schools of Pharmacy, Medicine and Physiotherapy as well as postgraduate teaching in the School of Pharmacy and the RCSI structured PhD programmes.
The Department is also very research active and has thriving research programmes in the following areas:
- Organic synthesis/methodology underpinning drug discovery.
- Peptide-based antibiotic and anticancer agents, nanomedicines and drug delivery systems.
- Synthesis and pharmacological evaluation of metal-based anti cancer agents.
- New inhibitors of cyclooxygenase (see Fig) as anti-inflammatory agents.
- Drugs from natural sources.
- Computer-aided drug design targeting cardiovascular diseases (thrombosis, hypertension), infectious diseases (malaria, MRSA, HIV), neurodegenerative diseases and cancer (bone metastasis, skin cancer).
The prostaglandin PGG2 bound to the peroxidase site of cyclooxygenase
